Medindia

X

Favorable Clinical Study Results Reported With Dual Anti-Platelet Therapy After LAA Closure With WATCHMAN® Device

Wednesday, May 18, 2011 General News J E 4
Advertisement
Results for Boston Scientific WATCHMAN device presented at EuroPCR

CONTACT:

Erik Kopp

508-650-8660 (office)

Media Relations

Boston Scientific Corporation

erik.kopp@bsci.com

Sean Wirtjes

508-652-5305 (office)

Investor Relations

Boston Scientific Corporation

investor_relations@bsci.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Anaphore Appoints Michael F. Haller, Ph.D., Senior...
S
PLC Medical Systems Adds Vice President of Clinica...